- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GH Research PLC (GHRS)
Assess today's live GH Research PLC (GHRS) share price, performance and insights using our live NASDAQ: GHRS stock exchange data.
Analyse the historical data and GH Research PLC share price performance charts on this page. Our technical summary section provides analysis on GH Research share price buy/sell indicators using real-time data (or discuss the GH Research (GHRS) stock price today with other investors in the GH Research NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ GHRS share price (ISIN: IE000GID8VI0) to enhance your trading decisions with our free investment tools and resources.
What Is the GH Research PLC Share Price Today?
The GH Research share price today is 21.71.
What Is the Stock Symbol for GH Research PLC
The stock symbol (or 'ticker') for GH Research PLC is "GHRS."
What Stock Exchange Does GH Research PLC Trade On?
GH Research PLC is listed and trades on the NASDAQ stock exchange.
Is GH Research PLC a Good Stock to Buy?
Determining whether GH Research PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and GH Research PLC share price performance charts on this page. Our technical summary section provides analysis on GH Research share price buy/sell indicators using real-time data (or discuss the GH Research (GHRS) stock price today with other investors in the GH Research NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ GHRS share price (ISIN: IE000GID8VI0) to enhance your trading decisions with our free investment tools and resources.
What Is the GH Research PLC Share Price Today?
The GH Research share price today is 21.71.
What Is the Stock Symbol for GH Research PLC
The stock symbol (or 'ticker') for GH Research PLC is "GHRS."
What Stock Exchange Does GH Research PLC Trade On?
GH Research PLC is listed and trades on the NASDAQ stock exchange.
Is GH Research PLC a Good Stock to Buy?
Determining whether GH Research PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
21.71
-0.83(-3.68%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.64
22.60
52 wk Range
10.66
24.66
GHRS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.6422.60
52 wk Range
10.6624.66
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GHRS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
39.50
Upside
+81.94%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings downwards for the upcoming period
- Form 13G GH Research PLC For: 18 May
- Investing.com
- Form 13G GH Research PLC For: 18 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 39.50
(+81.94% Upside)
Earnings
Latest Release
14/05/2026
EPS / Forecast
-0.31 / -0.29
Revenue / Forecast
-- / --
Compare GHRS to Peers and Sector
Metrics to compare | GHRS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGHRSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −27.0x | −3.6x | −0.5x | |
PEG Ratio | 1.76 | −0.05 | 0.00 | |
Price/Book | 5.8x | 3.8x | 2.6x | |
Price / LTM Sales | - | 6.5x | 3.1x | |
Upside (Analyst Target) | 64.2% | 195.5% | 54.0% | |
Fair Value Upside | Unlock | 19.8% | 6.5% | Unlock |
GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company’s lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the GH Research (NASDAQ: GHRS) Share Price Today?
The GH Research stock price today is 21.71 USD.
What Stock Exchange Does GH Research (GHRS) Trade On?
GH Research is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for GH Research?
The stock symbol (also called a 'ticker') for GH Research is "GHRS."
What Is the Current GH Research Market Capitalisation?
As of today, GH Research (NASDAQ: GHRS) market cap is 1.50B USD.
What Is GH Research's (GHRS) Earnings Per Share (TTM)?
The GH Research EPS is currently -0.91 (Trailing Twelve Months).
When Is the Next GH Research Earnings Date?
GH Research's next earnings report will be released on 26/08/2026.
Is GHRS a Buy or Sell From a Technical Analyst Perspective?
Based on today's GH Research moving averages and other technical indicators, the daily buy/sell signal for GHRS stock is Strong Buy.
How Many Times Has GH Research Stock Split?
GH Research has split 0 times. (See the GHRS stock split history page for full effective split date and price information.)
How Many Employees Does GH Research Have?
GH Research has 73 employees, based on their latest Companies House report.
What is the current trading status of GH Research (NASDAQ: GHRS)?
As of 21/05/2026, GH Research (GHRS) is trading at a share price of 21.71 USD, with a previous close of 22.54 USD. The stock has fluctuated within a day range of 21.64 USD to 22.60 USD, while its 52-week range spans from 10.66 USD to 24.66 USD.
What Is GH Research (GHRS) Price Target According to Analysts?
The average 12-month price target for GH Research is 39.50 USD, with a high estimate of 65 USD and a low estimate of 32 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +81.94% Upside potential.
What Is the GHRS Premarket Price?
GHRS's last pre-market stock price is 23.20 USD. The pre-market share volume is 630.00, and the stock has decreased by 0.66, or 2.93%.
What Is the GHRS After Hours Price?
GHRS's last after hours stock price is 22.90 USD, the stock has decreased by 0.36, or 1.60%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.